Synergistic activation of human platelets by lysophosphatidic acid and adrenaline

Haematologica

Volumn 87, Issue 7, 2002, Pages 730-739

  Nilsson, Ulrika K ^a   Svensson, Samuel P S ^a   Grenegård, Magnus ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Adrenaline; Aggregation; Calcium; Lysophosphatidic acid; Platelets; Tyrosine phosphorylation

Indexed keywords

ADRENALIN; CALCIUM ION; LYSOPHOSPHATIDIC ACID; CALCIUM; LYSOPHOSPHOLIPID;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; SPECTROFLUOROMETRY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; CALCIUM SIGNALING; DRUG EFFECT; METABOLISM; SECRETION; THROMBOCYTE;

BLOOD PLATELETS; CALCIUM; CALCIUM SIGNALING; DRUG SYNERGISM; EPINEPHRINE; HUMANS; LYSOPHOSPHOLIPIDS; PLATELET ACTIVATION;

EID: 0036070493     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells
2. Platelet-derived lysophosphatidic acid decreases endothelial permeability in vitro
3. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
4. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
5. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid
6. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
7. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid
8. Selective ligands for lysophosphatidic acid receptor subtypes: Gaining control over endothelial differentiation gene family
9. Identification of lysophospholipid receptors in human platelets: The relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate
10. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edgreceptor independent
11. 2+ indicators with greatly improved fluorescence properties
12. 2+
13. Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors
14. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives
15. Activation of human platelets by lysophosphatidic acid
16. Synergistic inhibition of thrombin-induced platelet aggregation by the novel nitric oxide-donor GEA 3175 and adenosine
17. Significance of testing platelet functions in vitro
18. Molecular mechanisms of platelet activation
19. 2+ influx in human platelets
20. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation
21. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation
22. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: Comparison with platelet activating factor
23. Exposure of platelet fibrinogen receptors by ADP and epinephrine
24. Spacial isolation of protein kinase C activation in thrombin stimulated human platelets
25. Activation of phospholipases A and C in human platelets exposed to epinephrine: Role of glycoproteins IIb/IIIa and dual role of epinephrine
26. 2-adrenergic receptor
27. Characterisation of human platelet adrenoceptors
28. 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro
29. Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy
30. 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans
31. Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets
32. Regulation of protein tyrosine kinases in platelets
33. Tyrosine phosphorylation and Syk activation are involved in thrombin-induced aggregation of epinephrine-potentiated platelets
34. Fibrinogen binding to purified platelet glycoprotein IIb-IIIa (integrin αIIbβ3) is modulated by lipids
35. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
36. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
37. Pharmacologically active acidic phospholipids and glycolipids
38. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
39. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta